All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials
The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Abstract
Statins and omega-3 supplementation have shown potential benefits in preventing cardiovascular disease (CVD), but their comparative effects on mortality outcomes, in addition to primary and secondary prevention and mixed population, have not been investigated. This study aimed to examine the effect of statins and omega-3 supplementation and indirectly compare the effects of statin use and omega-3 fatty acids on all-cause mortality and CVD death. We included randomized controlled trials (RCTs) from meta-analyses published until December 2019. Pooled relative risks (RRs) and 95% confidence intervals (CIs) were calculated to indirectly compare the effect of statin use versus omega-3 supplementation in a frequentist network meta-analysis. In total, 55 RCTs were included in the final analysis. Compared with placebo, statins were significantly associated with a decreased the risk of all-cause mortality (RR = 0.90, 95% CI = 0.86–0.94) and CVD death (RR = 0.86, 95% CI = 0.80–0.92), while omega-3 supplementation showed a borderline effect on all-cause mortality (RR = 0.97, 95% CI = 0.94–1.01) but were significantly associated with a reduced risk of CVD death (RR = 0.92, 95% CI = 0.87–0.98) in the meta-analysis. The network meta-analysis found that all-cause mortality was significantly different between statin use and omega-3 supplementation for overall population (RR = 0.91, 95% CI = 0.85–0.98), but borderline for primary prevention and mixed population and nonsignificant for secondary prevention. Furthermore, there were borderline differences between statin use and omega-3 supplementation in CVD death in the total population (RR = 0.92, 95% CI = 0.82–1.04) and primary prevention (RR = 0.85, 95% CI = 0.68–1.05), but nonsignificant differences in secondary prevention (RR = 0.97, 95% CI = 0.66–1.43) and mixed population (RR = 0.92, 95% CI = 0.75–1.14). To summarize, statin use might be associated with a lower risk of all-cause mortality than omega-3 supplementation. Future direct comparisons between statin use and omega-3 supplementation are required to confirm the findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures














Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, meta-analyses of omega-3 trials, whilst assessing major cardiovascular events, have paid no or little attention to the effects on coronary revascularizations.”
From Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis (2024) · cites this paper as [39]
In the citing paper
“Particularly, effects on coronary revascularization are unclear”
From Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis (2024) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Funnel plots for detecting bias in meta-analysis
Sterne, J. A. C., & Egger, M. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00377-8 · Cited by 3,779
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043545 · Cited by 2,614
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Miller, N. H., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437740.48606.d1 · Cited by 2,261
Self-citationRosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Fellström, B. C., Jardine, A. G., Schmieder, R. E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.-W., Chevaile, A., Cobbe, S. M., Grönhagen-Riska, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810177 · Cited by 2,036
Pedersen, T. R. (2005) · JAMA · doi:10.1001/jama.294.19.2437 · Cited by 1,548
Rosuvastatin in older patients with systolic heart failure
Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706201 · Cited by 1,487
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2998 · Cited by 1,331
Orsini, N., Li, R., Wolk, A., Khudyakov, P., & Spiegelman, D. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr265 · Cited by 1,280
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61240-4 · Cited by 1,106
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Albert, C. M., Gordon, D., Copeland, T., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811403 · Cited by 979
Self-citationNakamura, H., Arakawa, K., Itakura, H., Kitabatake, A., Goto, Y., Toyota, T., Nakaya, N., Nishimoto, S., Muranaka, M., Yamamoto, A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69472-5 · Cited by 941
n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
Furberg, C. D., Adams, H. P., Applegate, W. B., Byington, R. P., Espeland, M. A., Hartwell, T., Hunninghake, D. B., Lefkowitz, D. S., Probstfield, J., & Riley, W. A. (1994) · Circulation · doi:10.1161/01.cir.90.4.1679 · Cited by 867
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Yusuf, S., Bosch, J., Dagenais, G., Zhu, J., Xavier, D., Liu, L., Pais, P., López-Jaramillo, P., Leiter, L. A., Dans, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600176 · Cited by 848
Andrieu, S., Guyonnet, S., Coley, N., Cantet, C., Bonnefoy, M., Bordes, S., Bories, L., Cufi, M.-N., Dantoine, T., Dartigues, J.-F., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30040-6 · Cited by 838
Chan, K. L., Teo, K., Dumesnil, J. G., Ni, A., & Tam, J. (2010) · Circulation · doi:10.1161/circulationaha.109.900027 · Cited by 815
Serruys, P. W. J. C. (2002) · JAMA · doi:10.1001/jama.287.24.3215 · Cited by 719
Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
The ASCEND Study Collaborative Group (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804989 · Cited by 698
Network meta-analysis: application and practice using Stata
Shim, S., Yoon, B.-H., Shin, I.-S., & Bae, J.-M. (2017) · Epidemiology and Health · doi:10.4178/epih.e2017047 · Cited by 656
Blankenhorn, D. H., Azen, S. P., Kramsch, D. M., Mack, W. J., Cashin-Hemphill, L., Hodis, H. N., DeBoer, L. W. V., Mahrer, P. R., Masteller, M. J., Vailas, L. I., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00002 · Cited by 637
Siscovick, D. S., Barringer, T. A., Fretts, A. M., Wu, J. H. Y., Lichtenstein, A. H., Costello, R. B., Kris-Etherton, P. M., Jacobson, T. A., Engler, M. B., Alger, H. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000482 · Cited by 629
Rauch, B., Schiele, R., Schneider, S., Diller, F., Victor, N., Gohlke, H., Gottwik, M., Steinbeck, G., Del Castillo, U., Sack, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.948562 · Cited by 607
Knopp, R. H., d’Emden, M., Smilde, J. G., Pocock, S. J., & on behalf of the ASPEN Study Group (2006) · Diabetes Care · doi:10.2337/dc05-2415 · Cited by 550
Athyros, V. G., Papageorgiou, A. A., Mercouris, B. R., Athyrou, V. V., Symeonidis, A. N., Basayannis, E. O., Demitriadis, D. S., & Kontopoulos, A. G. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000787 · Cited by 533
Sever, P. S., Dahl??f, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2004) · Drugs · doi:10.2165/00003495-200464002-00005 · Cited by 524
Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria
Asselbergs, F. W., Diercks, G. F. H., Hillege, H. L., van Boven, A. J., Janssen, W. M. T., Voors, A. A., de Zeeuw, D., de Jong, P. E., van Veldhuisen, D. J., & van Gilst, W. H. (2004) · Circulation · doi:10.1161/01.cir.0000146378.65439.7a · Cited by 523
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
The Risk and Prevention Study Collaborative Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205409 · Cited by 510
Galan, P., Kesse-Guyot, E., Czernichow, S., Briancon, S., Blacher, J., Hercberg, S., & for the SU.FOL.OM3 Collaborative Group (2010) · BMJ · doi:10.1136/bmj.c6273 · Cited by 457
Hu, Y., Hu, F. B., & Manson, J. E. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013543 · Cited by 388
Raitt, M. H., Connor, W. E., Morris, C., Kron, J., Halperin, B., Chugh, S. S., McClelland, J., Cook, J., MacMurdy, K., Swenson, R., et al. (2005) · JAMA · doi:10.1001/jama.293.23.2884 · Cited by 371
Dangour, A. D., Allen, E., Elbourne, D., Fasey, N., Fletcher, A. E., Hardy, P., Holder, G. E., Knight, R., Letley, L., Richards, M., et al. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29121 · Cited by 296
Brouwer, I. A., Zock, P. L., Camm, A. J., Böcker, D., Hauer, R. N. W., Wever, E. F. D., Dullemeijer, C., Ronden, J. E., Katan, M. B., Lubinski, A., et al. (2006) · JAMA · doi:10.1001/jama.295.22.2613 · Cited by 287
Teo, K. K., Burton, J. R., Buller, C. E., Plante, S., Catellier, D., Tymchak, W., Dzavik, V., Taylor, D., Yokoyama, S., & Montague, T. J. (2000) · Circulation · doi:10.1161/01.cir.102.15.1748 · Cited by 275
Alexander, D. D., Miller, P. E., Van Elswyk, M. E., Kuratko, C. N., & Bylsma, L. C. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.10.018 · Cited by 251
Ford, I., Murray, H., McCowan, C., & Packard, C. J. (2016) · Circulation · doi:10.1161/circulationaha.115.019014 · Cited by 238
Sawayama, Y., Shimizu, C., Maeda, N., Tatsukawa, M., Kinukawa, N., Koyanagi, S., Kashiwagi, S., & Hayashi, J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01783-1 · Cited by 226
Nilsen, D. W., Albrektsen, G., Landmark, K., Moen, S., Aarsland, T., & Woie, L. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.1.50 · Cited by 203
Yebyo, H. G., Aschmann, H. E., Kaufmann, M., & Puhan, M. A. (2019) · American Heart Journal · doi:10.1016/j.ahj.2018.12.007 · Cited by 178
Effect of Change in Total Cholesterol Levels on Cardiovascular Disease Among Young Adults
Jeong, S., Choi, S., Kim, K., Kim, S. M., Lee, G., Park, S. Y., Kim, Y., Son, J. S., Yun, J., & Park, S. M. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008819 · Cited by 172
Oscarsson, J., & Hurt-Camejo, E. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0541-3 · Cited by 158
Heart Protection Study Collaborative Group (2011) · The Lancet · doi:10.1016/s0140-6736(10)62174-5 · Cited by 158
Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation
Macchia, A., Grancelli, H., Varini, S. D., Nul, D. R., Laffaye, N., Mariani, J. A., Ferrante, D., Badra, R., Figal, J. C., Ramos, S., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.021 · Cited by 152
Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial
Liem, A. H., Boven, A. J. V., Veeger, N. J. G. M., Withagen, A. J. A. M., de Medina, R. M. R., Tijssen, J. G. P., & van Veldhuisen, D. J. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3291 · Cited by 126
Riegger, G. A. J., Abletshauser, C., Ludwig, M. Z., SCHWANDT, P., Widimsky, J., Jr., Weidinger, G., & Welzel, D. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00062-3 · Cited by 122
Bonds, D. E., Harrington, M., Worrall, B. B., Bertoni, A. G., Eaton, C. B., Hsia, J., Robinson, J., Clemons, T. E., Fine, L. J., & Chew, E. Y. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.328 · Cited by 118
Qin, Y., Zhou, Y., Chen, S.-H., Zhao, X.-L., Ran, L., Zeng, X.-L., Wu, Y., Chen, J.-L., Kang, C., Shu, F.-R., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133496 · Cited by 101
Bestehorn, H.-P., Rensing, U. F. E., Roskamm, H., Betz, P., Benesch, L., Schemeitat, K., Blumchen, G., Claus, J., Mathes, P., Kappenberger, L., et al. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015224 · Cited by 101
Einvik, G., Ole Klemsdal, T., Sandvik, L., & Hjerkinn, E. M. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328339cc70 · Cited by 89
Bird, J. K., Calder, P. C., & Eggersdorfer, M. L. (2018) · Nutrients · doi:10.3390/nu10060775 · Cited by 80
Takano, H., Mizuma, H., Kuwabara, Y., Sato, Y., Shindo, S., Kotooka, N., Fujimatsu, D., Kobayashi, Y., Inoue, T., Node, K., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-1062 · Cited by 51
Statin and Cancer Mortality and Survival: An Umbrella Systematic Review and Meta-Analysis
Jeong, G. H., Lee, K. H., Kim, J. Y., Eisenhut, M., Kronbichler, A., van der Vliet, H. J., Shin, J. I., & Gamerith, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020326 · Cited by 47
Self-citationThe Potential Role of Biomarkers Associated with ASCVD Risk: Risk-Enhancing Biomarkers
Choi, S. (2019) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2019.8.2.173 · Cited by 47
Reduction in coronary events during treatment with pravastatin
Furberg, C. D., Pitt, B., Byington, R. P., Park, J.-S., McGovern, M. E., & The PLAC I and PLAC II Investigators (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80472-x · Cited by 46
Tada, H., Nohara, A., & Kawashiri, M.-A. (2018) · Nutrients · doi:10.3390/nu10111789 · Cited by 45
Kim, C. H., Han, K. A., Yu, J., Lee, S. H., Jeon, H. K., Kim, S. H., Kim, S. Y., Han, K. H., Won, K., Kim, D.-B., et al. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.11.007 · Cited by 36
Self-citationKim, J., Hoang, T., Bu, S. Y., Kim, J., Choi, J., Park, E., Min, J. Y., Park, E., Min, J. Y., Lee, I. S., et al. (2020) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2020.9.1.205 · Cited by 35
Self-citationMakuuchi, H., Furuse, A., Endo, M., Nakamura, H., Daida, H., Watanabe, M., Ohashi, Y., Hosoda, Y., Hosoda, S., Yamaguchi, H., et al. (2005) · Circulation Journal · doi:10.1253/circj.69.636 · Cited by 32
Ošťádal, P., Alan, D., Vejvoda, J., Kukačka, J., Maçek, M., Hájek, P., Mates, M., Kvapil, M., Kettner, J., Wiendl, M., et al. (2010) · Trials · doi:10.1186/1745-6215-11-61 · Cited by 31
Yokoi, H., Nobuyoshi, M., Mitsudo, K., Kawaguchi, A., Yamamoto, A., & for the ATHEROMA Study Group (2005) · Circulation Journal · doi:10.1253/circj.69.875 · Cited by 30
Choi, H. D., & Chae, S. M. (2018) · Medicine · doi:10.1097/md.0000000000013593 · Cited by 30
Muller, C. J., Noonan, C., MacLehose, R. F., Stoner, J. A., Lee, E. T., Best, L. G., Calhoun, D., Jolly, S. E., Devereux, R. B., & Howard, B. V. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012289 · Cited by 30
Lipworth, L., Fazio, S., Kabagambe, E., Munro, H., Nwazue, V., Tarone, R., McLaughlin, J., Blot, W., & Sampson, U. (2013) · Clinical Epidemiology · doi:10.2147/clep.s53492 · Cited by 26
Nakagawa, T., Kobayashi, T., Awata, N., Sato, S., Reiber, J. H. C., Nakajima, H., Toyama, Y., Hiraoka, H., Kato, O., Kirino, M., et al. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.11.002 · Cited by 24
Jun, J. E., Jeong, I., Yu, J. M., Kim, S. R., Lee, I. K., Han, K. A., Choi, S. H., Kim, S., Park, H. K., Mok, J., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0265 · Cited by 18
Self-citationHoang, T., & Kim, J. (2020) · Nutrients · doi:10.3390/nu12082218 · Cited by 16
Self-citationMeta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone
Doshi, R. P., Kumar, A., Thakkar, S. J., Shariff, M., Adalja, D., Doshi, A., Taha, M., Gupta, R., Desai, R., Shah, J., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.10.009 · Cited by 14
An, K., Huang, R., Tian, S., Guo, D., Wang, J., Lin, H., & Wang, S. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1053-0 · Cited by 14
Chen, P.-H., Wang, J., Lin, S.-Y., Li, C.-H., Wang, C.-Y., Hu, C.-Y., Fu, C., Tsai, Y.-T., Lee, A.-T., Chen, Y., et al. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1439829 · Cited by 10
Research works printed but not linked: 7
- Arnett, 2019, 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines, Circulation, 140, e596
- Bikdeli, 2014, Omega-3 supplements and cardiovascular diseases, Tanaffos, 13, 6
- Abdelhamid, 2018, Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease, Cochrane Database Syst. Rev., 7, CD003177
- Gissi, 1999, Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico, Lancet, 354, 447, 10.1016/S0140-6736(99)07072-5 · DOI · Paper page
- Koren, 2004, Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: The alliance study, J. Am. Coll Cardiol., 44, 1772
- Karam, 2008, High-dose atorvastatin after stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators, N. Engl. J. Med., 3, 68
- Scandinavian Simvastatin Survival Study Group (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet, 344, 1383–1389. · DOI · Paper page
Cited by
Dinu, M., Sofi, F., Lotti, S., Colombini, B., Mattioli, A. V., Catapano, A. L., Casula, M., Baragetti, A., Wong, N. D., Steg, P. G., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae184 · Cited by 43
Metadata
- Authors
- Kim, J., Hoang, T., Kim, J.-M., Bu, S. Y., Choi, J.-H., Park, E., Lee, S.-M., Park, E., Min, J. Y., Lee, I. S., Youn, S. Y., & Yeon, J.-Y.
- Affiliations
- Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Korea
- Food and Nutrition Major, Division of Food Science and Culinary Arts, Shinhan University, Uijeongbu 11644, Korea
- Department of Food and Nutrition, Daegu University, Gyeongsan 38453, Korea
- Department of Food and Nutrition, Keimyung University, Daegu 42601, Korea
- Department of Food and Nutrition, Kyungnam University, Changwon 51767, Korea
- Department of Food and Nutrition, Yonsei University, Seoul 03722, Korea
- Department of Food and Nutrition, Hannam University, Daejeon 34430, Korea
- Dietetics and Nutrition Services Team, Asan Medical Center, Seoul 05505, Korea
- Nutrition Support Team, Kyung Hee University Medical Center, Seoul 02447, Korea
- Clinical Nutrition Part, Samsung Medical Center, Seoul 06351, Korea
- Department of Food and Nutrition, Seowon University, Cheongju 28674, Korea
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-10-20
- Volume
- 12
- Issue
- 10
- Pages
- 3203
- ISSN
- 2072-6643
- PMC
- PMC7590109
- Cited by
- 8
- References
- 82
- Language
- en
- Funders
- Korean Society of Lipid and Atherosclerosis (NA)
- National Cancer Center, Korea (1910330)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.